First-in-human Study of CCW702 in Patients With Metastatic Castration Resistant Prostate Cancer

NCT04077021 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

22

Enrollment

OTHER

Sponsor class

Stopped Business decision

Conditions

Metastatic Castration-Resistant Prostate Adenocarcinoma

Interventions

DRUG: CCW702

Sponsor

Calibr, a division of Scripps Research